Your browser doesn't support javascript.
loading
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
Kateete, David Patrick; Kamulegeya, Rogers; Kigozi, Edgar; Katabazi, Fred Ashaba; Lukoye, Deus; Sebit, Sindani Ireneaus; Abdi, Hergeye; Arube, Peter; Kasule, George William; Musisi, Kenneth; Dlamini, Myalo Glen; Khumalo, Derrick; Joloba, Moses L.
Afiliação
  • Kateete DP; Department of Immunology and Molecular Biology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda. dkateete@chs.mak.ac.ug.
  • Kamulegeya R; Department of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda. dkateete@chs.mak.ac.ug.
  • Kigozi E; Department of Immunology and Molecular Biology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
  • Katabazi FA; Department of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
  • Lukoye D; Department of Immunology and Molecular Biology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
  • Sebit SI; Department of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
  • Abdi H; Department of Immunology and Molecular Biology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
  • Arube P; Department of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
  • Kasule GW; National Tuberculosis/Leprosy Program, Ministry of Health Uganda, Kampala, Uganda.
  • Musisi K; WHO, Hargeisa, Somaliland, Somalia.
  • Dlamini MG; Ministry of Health, Hargeisa, Somaliland, Somalia.
  • Khumalo D; World Vision International, Nairobi, Kenya.
  • Joloba ML; National Tuberculosis Reference Laboratory, Kampala, Uganda.
BMC Pulm Med ; 19(1): 124, 2019 Jul 10.
Article em En | MEDLINE | ID: mdl-31291943
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Farmacorresistência Bacteriana Múltipla / Mutação / Mycobacterium tuberculosis Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Revista: BMC Pulm Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Uganda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Farmacorresistência Bacteriana Múltipla / Mutação / Mycobacterium tuberculosis Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Revista: BMC Pulm Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Uganda